文献速递肺栓塞与肺血管病

基于单一临床问题的D-二聚体阈值诊断肺栓塞的前瞻性研究

D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional study.
PubMed 文献 · Lancet Respir Med · 2025-10-21

本研究在法国13家医院急诊科前瞻性纳入1221例临床疑诊肺栓塞的成人患者,采用简化策略:肺栓塞非最可能诊断且D-二聚体<1000 ng/mL者不做胸部影像学检查排除肺栓塞,其余患者采用年龄校正阈值。

要点

  • 肺栓塞非最可能诊断且D-二聚体<1000 ng/mL者可安全免于胸部影像学检查
  • 胸部影像学检查率32%,较固定500 ng/mL阈值策略绝对降低19%(95%CI 16-21)

核心结论

  • 在肺栓塞非最可能诊断的患者中采用1000 ng/mL的D-二聚体阈值、其余患者采用年龄校正阈值,可安全排除肺栓塞并减少急诊胸部影像学检查的使用。

研究设计与样本

  • 前瞻性、多中心、开放标签、单臂干预研究,在法国13家医院急诊科开展。
  • 纳入年龄≥18岁、临床疑诊肺栓塞、未接受全剂量抗凝且近6个月无血栓栓塞事件的患者。
  • 共筛查1365例,最终纳入1221例,其中80例(7%)在初始检查时诊断为肺栓塞。

主要发现

  • 策略胸部影像学检查率为32%(384/1217),较固定500 ng/mL阈值策略(609/1215,50%)绝对降低19%(95%CI 16-21)。
  • 3个月随访期间共16例死亡。

关键数值与推荐

  • 肺栓塞非最可能诊断且D-二聚体<1000 ng/mL者不做胸部影像学检查即排除肺栓塞。
  • 其余患者采用年龄校正D-二聚体阈值:<50岁为500 ng/mL,≥50岁为年龄×10 ng/mL。
  • 主要结局为初始排除肺栓塞患者3个月随访内血栓栓塞事件的发生率。

临床怎么用

  • 对急诊疑诊肺栓塞患者,可先判断肺栓塞是否为最可能诊断,非最可能且D-二聚体<1000 ng/mL时可考虑不做胸部影像学检查。
  • 对肺栓塞为最可能诊断或其他患者,采用年龄校正D-二聚体阈值决定是否进一步影像学检查。

局限性

  • 单臂设计,未设随机对照。
  • 33例患者无随访数据,需多重插补分析。
  • 研究仅在法国13家医院急诊科开展,外推性需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Validated diagnostic strategies for pulmonary embolism allow raising the D-dimer threshold to 1000 ng/mL in selected patients with a low probability of pulmonary embolism, but adherence to this strategy in routine practice remains poor. Retrospective studies suggest that these rules could be replaced by a single clinical question as to whether pulmonary embolism is the most likely diagnosis. We aimed to assess the safety of a simplified approach that applies a 1000 ng/mL threshold when pulmonary embolism is unlikely and an age-adjusted threshold otherwise, including patients at a high probability for pulmonary embolism. METHODS: In this prospective interventional study in 13 French hospital emergency departments, patients aged ≥18 years with a clinical suspicion of pulmonary embolism, who were not on full-dose anticoagulant therapy and had not had a thromboembolic event in the past 6 months, were included. The intervention consisted of ruling out pulmonary embolism without chest imaging in patients for whom pulmonary embolism was not considered the most likely diagnosis and had a D-dimer value <1000 ng/mL. The age-adjusted D-dimer threshold (500 ng/mL if aged <50 years or age × 10 ng/mL if aged ≥50 years) was used for the other patients. The primary outcome was the diagnostic failure rate (ie, occurrence of a thromboembolic event at 3 months of follow-up) among patients for whom pulmonary embolism was initially ruled out. Safety was established if the upper bound of the two-sided 95% CI for the diagnostic failure rate was less than 1·85% in patients for whom pulmonary embolism was ruled out at initial testing and in a subgroup of patients for whom it was ruled out without chest imaging. This study is registered with ClinicalTrials.gov (NCT06190392) and is complete. FINDINGS: Between Jan 16 and Sept 5, 2024, 1365 patients were screened for eligibility and 1221 were included, of whom 80 (7%) were diagnosed with pulmonary embolism at initial testing. Pulmonary embolism was not considered the most likely diagnosis for 997 patients. The diagnostic failure rate was 0·00% (95% CI 0·00-0·34) and was 0·12% (0·01-0·55) after multiple imputation for 33 patients with no available follow-up, both within the safety threshold. In the prespecified subgroup of 796 patients for whom pulmonary embolism was ruled out without chest imaging, the diagnostic failure rate was 0·00% (0·00-0·46), also within the safety threshold. The strategy had a 32% chest imaging rate (384 of 1217 patients), an absolute reduction of 19% (16-21) compared with the fixed 500 ng/mL D-dimer threshold strategy (609 [50%] of 1215). There were 16 deaths during the 3-month follow-up. INTERPRETATION: A global simplified strategy using a D-dimer threshold of 1000 ng/mL in patients for whom pulmonary embolism was not the most likely diagnosis, and an age-adjusted threshold for other patients, safely excluded the diagnosis. These findings indicate that this simplified strategy could safely reduce the use of chest imaging in the emergency department. FUNDING: Assistance Publique-Hôpitaux de Paris (Délégation à la Recherche Clinique et à l'Innovation).

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Roussel M, Bannelier H, Lebal S, et al. D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional study. Lancet Respir Med. 2025. PMID: 41135553. doi:10.1016/S2213-2600(25)00292-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。